PODCAST by Brian Culley - Beyond Biotech - Spinal cord injuries impact millions of people worldwide and, unlike many chronic injuries, they usually arrive with no forewarning, impacting the young and old alike. Brian Culley is CEO of Lineage Cell Therapeutics and his...

By Bill Hathaway - Yale Health & Medicine - Yale scientists have developed a CRISPR technology that can assess genetic interactions on a host of immunological responses to multiple diseases, including cancer. Advances in the gene-editing technology known as...

By Tim Bertram - Pharmaphorum - The field of regenerative medicine is advancing rapidly, offering transformative solutions for a wide range of health conditions. However, while scientific breakthroughs in regenerative medicines like cell and gene therapies continue,...

“An important step towards slowing aging and the onset of major age-related chronic diseases” Washington, DC and San Francisco, CA, March 27, 2025— The Healthspan Action Coalition (HSAC) and the Kitalys Institute jointly proposed today the initial draft of a bill...

By Dennis Nealon - Harvard Research - Research led by new faculty member Michael Segel focuses on mammalian lifespans Sixteen years ago, Michael Segel was a rising senior at Brookline High School in Massachusetts when, acting on a friend’s suggestion, he signed on for...

By University of California - Santa Cruz - SciTechDaily - Scientists have found a way to study early embryonic development without real embryos. Using CRISPR, they programmed stem cells to self-organize into structures mimicking early embryos. The cells show...

By by Rachael Robertson MedPageToday - After HHS Secretary Robert F. Kennedy Jr. hosted a roundtableopens in a new tab or window on reducing regulations on stem cells earlier this month, experts have raised concerns about a potential flourishing of questionable stem...

By Technology Networks - Reprogrammed stem cells to replace dopamine cells in the brain may offer hope for Parkinson's treatment. A recently launched Phase 1 clinical trial at Mass General Brigham is examining the safety and feasibility of a groundbreaking treatment...

By Mass General Brigham - A recently launched Phase 1 clinical trial at Mass General Brigham is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson’s disease in which a patient’s stem cells are reprogrammed to replace dopamine...

By Frank Vinluan - MedCity News - Neurotech Pharmaceuticals’ surgically implanted cell and gene therapy, Encelto, is now FDA approved to treat macular telangectasia type 2 (MacTel). It’s the first therapy for this rare retinal degeneration disorder. Protein therapies...

by Morgridge Institute for Research - MedicalXpress - Scientists at the Wisconsin National Primate Research Center (WNPRC) and the Morgridge Institute for Research at the University of Wisconsin–Madison have been at the forefront of stem cell research and regenerative...

by Laura Kelley - University of Colorado Cancer Center - Researchers at CU Anschutz Medical Campus have developed ALA-CART, a next-generation therapy aimed at improving outcomes for patients with resistant cancers. “This next-generation approach, called ALA-CART...